Get the Stockscreener App
21.10
0.42%
-0.09
Overview
News
Price History
Option Chain
Financials
Why KVUE Down?
Discussions
Forecast
Dividend History
Kenvue Inc stock is traded at $21.10, with a volume of 11.05M.
It is down -0.42% in the last 24 hours and down -4.26% over the past month.
Kenvue is the world's largest pure-play consumer health company by sales, generating $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio includes a wide array of some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and ever-changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.
See More
Previous Close:
$21.19
Open:
$21.2
24h Volume:
11.05M
Relative Volume:
0.87
Market Cap:
$40.45B
Revenue:
$15.46B
Net Income/Loss:
$1.06B
P/E Ratio:
38.36
EPS:
0.55
Net Cash Flow:
$1.40B
1W Performance:
+1.20%
1M Performance:
-4.26%
6M Performance:
+14.43%
1Y Performance:
+0.57%
1-Day Range:
$21.03
$21.34
1-Week Range:
$20.70
$21.34
52-Week Range:
$17.67
$24.46
Kenvue Inc Stock (KVUE) Company Profile
Name
Kenvue Inc
Sector
Industry
Phone
908-874-1200
Address
199 GRANDVIEW ROAD, SKILLMAN
Compare KVUE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KVUE
Kenvue Inc
|
21.10 | 40.45B | 15.46B | 1.06B | 1.40B | 0.55 |
|
PG
Procter Gamble Co
|
161.13 | 379.47B | 83.91B | 14.32B | 15.85B | 5.80 |
|
UL
Unilever Plc Adr
|
55.66 | 137.66B | 64.93B | 7.15B | 0 | 2.832 |
|
CL
Colgate Palmolive Co
|
88.69 | 72.46B | 20.11B | 2.87B | 3.40B | 3.49 |
|
KMB
Kimberly Clark Corp
|
127.22 | 42.43B | 20.10B | 2.61B | 2.90B | 7.71 |
Kenvue Inc Stock (KVUE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-06-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-12-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Sep-24-24 | Initiated | Jefferies | Buy |
| Sep-24-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| May-28-24 | Resumed | Citigroup | Neutral |
| Apr-11-24 | Initiated | Bernstein | Underperform |
| Apr-03-24 | Initiated | William Blair | Mkt Perform |
| Mar-01-24 | Resumed | Goldman | Neutral |
| Nov-17-23 | Initiated | Piper Sandler | Neutral |
| Sep-11-23 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-07-23 | Initiated | Canaccord Genuity | Buy |
| Sep-06-23 | Initiated | Argus | Hold |
| Aug-24-23 | Upgrade | Goldman | Neutral → Buy |
| Jul-25-23 | Initiated | Edward Jones | Buy |
| Jun-01-23 | Initiated | HSBC Securities | Hold |
| May-30-23 | Initiated | BofA Securities | Buy |
| May-30-23 | Initiated | Citigroup | Neutral |
| May-30-23 | Initiated | Deutsche Bank | Hold |
| May-30-23 | Initiated | Exane BNP Paribas | Neutral |
| May-30-23 | Initiated | Goldman | Neutral |
| May-30-23 | Initiated | JP Morgan | Overweight |
| May-30-23 | Initiated | RBC Capital Mkts | Outperform |
| May-30-23 | Initiated | UBS | Neutral |
View All
Kenvue Inc Stock (KVUE) Latest News
Kenvue Inc. (NYSE:KVUE) Shares Sold by Procyon Advisors LLC - MarketBeat
Verity & Verity LLC Acquires 19,697 Shares of Kenvue Inc. (NYSE:KVUE) - MarketBeat
Kenvue (NYSE:KVUE) Will Pay A Dividend Of $0.205 - Yahoo Finance
24,474 Shares in Kenvue Inc. (NYSE:KVUE) Acquired by Joule Financial LLC - MarketBeat
Kenvue Inc. (NYSE:KVUE) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Avanza Fonder AB Invests $4.01 Million in Kenvue Inc. (NYSE:KVUE) - MarketBeat
Empirical Asset Management LLC Acquires Shares of 53,636 Kenvue Inc. (NYSE:KVUE) - MarketBeat
Kenvue Inc. (NYSE:KVUE) Sees Large Decline in Short Interest - MarketBeat
Assenagon Asset Management S.A. Purchases 616,292 Shares of Kenvue Inc. (NYSE:KVUE) - MarketBeat
Barclays Has Lowered Expectations for Kenvue (NYSE:KVUE) Stock Price - MarketBeat
Kenvue Inc. (NYSE:KVUE) Announces Quarterly Dividend of $0.21 - MarketBeat
UBS Group Has Lowered Expectations for Kenvue (NYSE:KVUE) Stock Price - MarketBeat
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever - The Motley Fool
Park Avenue Securities LLC Has $4.96 Million Position in Kenvue Inc. (NYSE:KVUE) - MarketBeat
Kenvue Expands Hydration Portfolio in India with WHO-Approved ORS Launch - Indian Retailer
Qorvo Soars 7% After Hours As Activist Investor Starboard Reportedly Takes Stake In Semiconductor Company - Benzinga
Kenvue names Somaya chief data & analytics officer - ROI-NJ.com
Vikram Somaya Named Chief Data & Analytics Officer of Kenvue - Consumer Goods Technology
Citigroup Cuts Kenvue (NYSE:KVUE) Price Target to $21.00 - MarketBeat
Kenvue announces $0.205 quarterly dividend - TradingPedia
Kenvue Declares Quarterly Cash Dividend -January 16, 2025 at 06:47 am EST - Marketscreener.com
Kenvue Declares $0.205 Quarterly Dividend, Showcases Strong Consumer Health Portfolio - StockTitan
Kenvue launches WHO-approved ORS amid past concerns - The Financial Express
What Analysts Are Saying About Kenvue Stock - Benzinga
Citigroup Issues Pessimistic Forecast for Kenvue (NYSE:KVUE) Stock Price - MarketBeat
Allen Mooney & Barnes Investment Advisors LLC Makes New Investment in Kenvue Inc. (NYSE:KVUE) - MarketBeat
Kenvue Inc. (NYSE:KVUE) Shares Bought by Czech National Bank - MarketBeat
Kenvue appoints CPG industry veteran Vikram Somaya as Chief Data and Analytics Officer - Retail Technology Innovation Hub
Kenvue Inc. stock rises Tuesday, outperforms market - MarketWatch
Will Kenvue (KVUE) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
OTC Drugs, Medical Devices and Diagnostics Market Analysis and Key Player Shares to 2029, Featuring Haleon Group of Co., Kenvue, Sanofi, and Bayer Among Others - Yahoo Finance
Kenvue 2024 in review: From brand innovation to key moments of everyday care -January 01, 2025 - Marketscreener.com
(KVUE) Long Term Investment Analysis - Stock Traders Daily
Douglas Lane & Associates LLC Has $1.98 Million Stock Holdings in Kenvue Inc. (NYSE:KVUE) - MarketBeat
2025The Year Of...: Convergence of technology, says Kenvue's Manish Anandani - Storyboard18
Kenvue Inc. stock rises Wednesday, outperforms market - MarketWatch
How To Put $100 In Your Retirement Fund Each Month With Kenvue Stock - Benzinga
Kenvue Inc. stock outperforms market despite losses on the day - MarketWatch
Nordea Investment Management AB Sells 587,409 Shares of Kenvue Inc. (NYSE:KVUE) - MarketBeat
Kenvue Inc. stock falls Monday, underperforms market - MarketWatch
Kenvue stock still has 'ample room': Piper Sandler By Investing.com - Investing.com Canada
Kenvue (NYSE:KVUE) Upgraded at Piper Sandler - MarketBeat
Piper Sandler bullish on Kenvue stock as margins and peer alignment improve - Investing.com
Everence Capital Management Inc. Raises Stock Position in Kenvue Inc. (NYSE:KVUE) - MarketBeat
Kenvue Inc.'s (NYSE:KVUE) Intrinsic Value Is Potentially 70% Above Its Share Price - Simply Wall St
Kenvue Inc. stock falls Friday, underperforms market - MarketWatch
Here’s Why Kenvue Inc. (KVUE) Is Among The Stocks Targeted By Activist Hedge Funds - Insider Monkey
15 Stocks Targeted By Activist Hedge Funds - Insider Monkey
Here's How You Can Earn $100 In Passive Income By Investing In Kenvue Stock - Yahoo Finance
Kenvue Enters Oversold Territory - Nasdaq
Learn to Evaluate (KVUE) using the Charts - Stock Traders Daily
Kenvue Inc Stock (KVUE) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.45%
0.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):